Follow
Sarah Davis
Sarah Davis
Verified email at sheffield.ac.uk - Homepage
Title
Cited by
Cited by
Year
The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of Technology Appraisal No. 111 …
M Bond, G Rogers, J Peters, R Anderson, M Hoyle, A Miners, T Moxham, ...
NIHR Evaluation, Trials and Studies Coordinating Centre (UK), 2012
3742012
A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis
M Stevenson, ML Jones, E De Nigris, N Brewer, S Davis, J Oakley
NIHR Evaluation, Trials and Studies Coordinating Centre (UK), 2005
3502005
Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis
JA Kanis, M Stevenson, EV McCloskey, S Davis, M Lloyd-Jones
NIHR Evaluation, Trials and Studies Coordinating Centre (UK), 2007
2102007
Taxanes for the adjuvant treatment of early breast cancer: systematic review and economic evaluation
S Ward, E Simpson, S Davis, D Hind, A Rees, A Wilkinson
NIHR Evaluation, Trials and Studies Coordinating Centre (UK), 2007
1342007
Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic model
C Hyde, J Peters, M Bond, G Rogers, M Hoyle, R Anderson, M Jeffreys, ...
Age and ageing 42 (1), 14-20, 2013
1282013
The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women
M Stevenson, S Davis, M Lloyd-Jones, C Beverley
NIHR Evaluation, Trials and Studies Coordinating Centre (UK), 2007
922007
The hospitalisation costs and out-patient costs of fragility fractures
MD Stevenson, SE Davis, JA Kanis
Women's Health Medicine 3 (4), 149-151, 2006
462006
Implantable loop recorders are cost-effective when used to investigate transient loss of consciousness which is either suspected to be arrhythmic or remains unexplained
S Davis, M Westby, D Pitcher, S Petkar
Europace 14 (3), 402-409, 2012
452012
The cost-effectiveness of lanthanum carbonate in the treatment of hyperphosphatemia in patients with end-stage renal disease
A Brennan, R Akehurst, S Davis, H Sakai, V Abbott
Value in health 10 (1), 32-41, 2007
422007
Using contrast sensitivity to estimate the cost-effectiveness of verteporfin in patients with predominantly classic age-related macular degeneration
N Bansback, S Davis, J Brazier
Eye 21 (12), 1455-1463, 2006
362006
A preliminary model-based assessment of the cost-utility of a screening programme for early age-related macular degeneration
J Karnon, C Czoski-Murray, K Smith, C Brand, U Chakravarthy, S Davis, ...
HEALTH TECHNOLOGY ASSESSMENT-SOUTHAMPTON- 12 (27), 2008
352008
A review of the psychometric performance of the EQ-5D in people with urinary incontinence
S Davis, A Wailoo
Health and Quality of Life Outcomes 11 (1), 20, 2013
342013
The cost-effectiveness of multi-component interventions to prevent delirium in older people undergoing surgical repair of hip fracture
A Akunne, S Davis, M Westby, J Young
European Journal of Orthopaedic Surgery & Traumatology 24 (2), 187-195, 2014
282014
Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying antirheumatic drugs: a NICE single technology appraisal
J Tosh, R Archer, S Davis, M Stevenson, JW Stevens
Pharmacoeconomics 31 (8), 653-661, 2013
222013
Analyses of the cost-effectiveness of pooled alendronate and risedronate, compared with strontium ranelate, raloxifene, etidronate and teriparatide
M Stevenson, S Davis
DSU Report, 2006
192006
Transient loss of consciousness (‘blackouts’) management in adults and young people
M Westby, S Davis, I Bullock, P Miller, P Cooper, N Turnbull
London: National Clinical Guideline Centre for Acute and Chronic Conditions …, 2010
162010
Tilt testing is more cost-effective than implantable loop recorder monitoring as a means of directing pacing therapy in people with recurrent episodes of suspected vasovagal …
S Davis, M Westby, S Petkar, D Pitcher
Heart 99 (11), 805-810, 2013
142013
Transient loss of consciousness--initial assessment, diagnosis, and specialist referral: summary of NICE guidance.
M Westby, I Bullock, PN Cooper, S Davis, Guideline Development Group
BMJ (Clinical research ed.) 341, c4457, 2010
102010
How do we evaluate technologies that are not cost effective at zero price
S Davis, R Akehurst
Value and Outcomes Spotlight 359, 6-8, 2016
92016
Transient loss of consciousness: summary of NICE guidance
S Petkar, I Bullock, S Davis, P Cooper
Heart 99 (13), 901-903, 2013
52013
The system can't perform the operation now. Try again later.
Articles 1–20